Midcareer Investigator Award in Patient-Oriented NeuroAIDS Research
以患者为导向的神经艾滋病研究中职业生涯调查员奖
基本信息
- 批准号:8774931
- 负责人:
- 金额:$ 18.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-12-07 至 2015-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAnti-Retroviral AgentsAppointmentAreaAwardBiological AssayBiological MarkersBrainChronic DiseaseClinical ResearchClinical Research Curriculum AwardClinical TrialsCollaborationsContinuing EducationCytomegalovirusDataDevelopmentDiagnosisDiagnosticDiseaseDoctor of MedicineDrug InteractionsDrug KineticsEducationEducation ProjectsEducational process of instructingEquipmentEventFacultyFellowshipFibroblast Growth FactorFundingGoalsGrantHIVHIV-associated neurocognitive disorderHepatitis C virusIndividualInfectionInfluentialsInstitutional National Research Service AwardInternationalJunior PhysicianK-Series Research Career ProgramsLaboratoriesLeadLeadershipLifeLightMeasurementMeasuresMedical StudentsMedicineMentorsMethodsMid-Career Clinical Scientist Award (K24)ModelingNational Institute of Mental HealthNebraskaNervous system structureNeurocognitiveNeurologicOutcomePerformancePharmaceutical PreparationsPharmacologyPlasmaPlasmodiumPopulationPostdoctoral FellowPrognostic MarkerProteinsRegimenResearchResearch InstituteResearch MethodologyResearch PersonnelResearch Project GrantsResourcesRisk FactorsRoleScientistSecureTimeToxoplasmaTrainingTranslational ResearchWagesWorkaddictionantimicrobialantiretroviral therapycareerco-infectioncostdesigndrug distributiongraduate studentinstrumentinterdisciplinary approachinterestlongitudinal analysisnervous system disorderneuroAIDSneurocognitive disorderneurofilamentoutcome forecastpathogenpatient orientedpatient oriented researchprofessorpublic health relevancescreeningskillssuccessyoung adult
项目摘要
DESCRIPTION (provided by applicant): Scott Letendre, M.D. is an Associate Professor of Medicine at UCSD and former K23 Career Development Award recipient. In the past decade, Dr. Letendre has led or collaborated on many publicly and privately funded translational research projects. His influential work has focused on the risk factors and treatment of HIV-associated neurocognitive disorder (HAND) in the US and international settings. During this period, he has also mentored more than 30 trainees in patient-oriented research, including graduate and medical students, post-doctoral researchers, and junior faculty. In the proposed K24 mid-career investigator award, Dr. Letendre will expand his mentoring of junior investigators and will focus his mentoring and his own research on three main objectives. Antiretroviral treatment of the nervous system: Dr. Letendre will mentor trainees on design and performance of HAND clinical trials and CSF pharmacology projects, particularly focusing on longitudinal projects that measure all drugs in an antiretroviral regimen to better understand how drug interactions and time influence virologic and neurocognitive outcomes. Biomarker correlates of disease and treatment: Dr. Letendre will mentor trainees on measurement and analysis of biomarker data with the goal of developing a clinically useful panel for screening, diagnosis, and prognosis of HAND. This work will be supported by new equipment purchased with funds from a recent S10 Shared Instrument Grant. Coinfections in HIV-infected individuals: Dr. Letendre will work with trainees on projects that evaluate the impact on the nervous system of latent or minimally symptomatic infections with pathogens such as Plasmodium, Cytomegalovirus, Toxoplasma, and hepatitis C virus. This work will particularly focus on Dr. Letendre's existing work in international settings. Dr. Letendre will mentor trainees using a multidisciplinary approach that includes regular direct engagement, participation in R25, T32, and K30 programs at UCSD, active participation in existing research projects, support for new research projects, and networking with other investigators. Dr. Letendre will also obtain training in mentoring and analysis of longitudinal data. In summary, this K24 award will secure protected time for Dr. Letendre to mentor trainees in neuroAIDS methods, including the responsible conduct of patient- oriented research. Dr. Letendre will coordinate his efforts with other UCSD resources, including the R25- funded "International Research Fellowship in NeuroAIDS", the T32-funded "Training in Research on Addictions in Interdisciplinary NeuroAIDS", and the CTSA-funded "Clinical and Translational Research Institute".
描述(由申请人提供):Scott Letendre,医学博士是UCSD的医学副教授和前K23职业发展奖获得者。在过去的十年中,Letendre博士领导或合作了许多公共和私人资助的转化研究项目。他有影响力的工作集中在美国和国际环境中艾滋病毒相关神经认知障碍(HAND)的风险因素和治疗。在此期间,他还指导了30多名以患者为导向的研究人员,包括研究生和医学生,博士后研究人员和初级教师。在拟议的K24职业中期研究者奖中,Letendre博士将扩大他对初级研究者的指导,并将他的指导和他自己的研究集中在三个主要目标上。神经系统的抗逆转录病毒治疗:Letendre博士将指导学员进行HAND临床试验和CSF药理学项目的设计和执行,特别是专注于测量抗逆转录病毒方案中所有药物的纵向项目,以更好地了解药物相互作用和时间如何影响病毒学和神经认知结果。疾病和治疗的生物标志物相关性:Letendre博士将指导学员测量和分析生物标志物数据,目的是开发一个临床有用的面板,用于HAND的筛查,诊断和预后。这项工作将得到新设备的支持,这些设备是用最近的S10共享仪器赠款购买的。艾滋病毒感染者的合并感染:Letendre博士将与学员一起开展项目,评估潜伏性或轻微症状的病原体感染对神经系统的影响,如疟原虫,巨细胞病毒,弓形虫和丙型肝炎病毒。这项工作将特别侧重于Letendre博士在国际环境中的现有工作。Letendre将使用多学科方法指导学员,包括定期直接参与,参与UCSD的R25,T32和K30计划,积极参与现有的研究项目,支持新的研究项目,并与其他研究人员建立联系。Letendre博士还将获得指导和纵向数据分析方面的培训。总之,这个K24奖将确保Letendre博士有受保护的时间指导神经艾滋病方法的学员,包括负责任地进行以患者为导向的研究。Letendre博士将与其他UCSD资源协调他的努力,包括R25资助的“神经艾滋病国际研究奖学金”,T32资助的“跨学科神经艾滋病成瘾研究培训”,以及CTSA资助的“临床和转化研究所”。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scott L Letendre其他文献
Neurocognitive effects of HCV, methamphetamine abuse, and HIV: multiple risks and mechanisms
- DOI:
10.1186/1744-859x-7-s1-s39 - 发表时间:
2008-04-17 - 期刊:
- 影响因子:3.100
- 作者:
Scott L Letendre - 通讯作者:
Scott L Letendre
Scott L Letendre的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scott L Letendre', 18)}}的其他基金
Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV
成人艾滋病毒感染者的衰老、多药治疗和神经毒性
- 批准号:
10577736 - 财政年份:2020
- 资助金额:
$ 18.26万 - 项目类别:
Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV
成人艾滋病毒感染者的衰老、多药治疗和神经毒性
- 批准号:
10374038 - 财政年份:2020
- 资助金额:
$ 18.26万 - 项目类别:
Aging, Polypharmacy and Neurotoxicity in Adults Living with HIV
成人艾滋病毒感染者的衰老、多药治疗和神经毒性
- 批准号:
10013739 - 财政年份:2020
- 资助金额:
$ 18.26万 - 项目类别:
Measurement of ART Drug Concentrations in Brain by 19F-MRS as an Indicator of Neurotoxicity
通过 19F-MRS 测量脑内 ART 药物浓度作为神经毒性指标
- 批准号:
10023281 - 财政年份:2019
- 资助金额:
$ 18.26万 - 项目类别:
Measurement of ART Drug Concentrations in Brain by 19F-MRS as an Indicator of Neurotoxicity
通过 19F-MRS 测量脑内 ART 药物浓度作为神经毒性指标
- 批准号:
9925549 - 财政年份:2019
- 资助金额:
$ 18.26万 - 项目类别:
Sustained Training in Aging and HIV Research (STAHR)
老龄化和艾滋病毒研究持续培训(STAHR)
- 批准号:
10483564 - 财政年份:2016
- 资助金额:
$ 18.26万 - 项目类别:
Sustained Training in Aging and HIV Research (STAHR)
老龄化和艾滋病毒研究持续培训(STAHR)
- 批准号:
10615240 - 财政年份:2016
- 资助金额:
$ 18.26万 - 项目类别:
Midcareer Investigator Award in Patient-Oriented NeuroAIDS Research
以患者为导向的神经艾滋病研究中职业生涯调查员奖
- 批准号:
8466639 - 财政年份:2012
- 资助金额:
$ 18.26万 - 项目类别:
Midcareer Investigator Award in Patient-Oriented NeuroAIDS Research
以患者为导向的神经艾滋病研究中职业生涯调查员奖
- 批准号:
8594262 - 财政年份:2012
- 资助金额:
$ 18.26万 - 项目类别:
Midcareer Investigator Award in Patient-Oriented NeuroAIDS Research
以患者为导向的神经艾滋病研究中职业生涯调查员奖
- 批准号:
8968863 - 财政年份:2012
- 资助金额:
$ 18.26万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 18.26万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 18.26万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 18.26万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 18.26万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 18.26万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 18.26万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 18.26万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 18.26万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 18.26万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 18.26万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




